Today in Medicine
SEE OTHER BRANDS

Fresh medicine news from the world

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Today in Medicine.

Clover Health Launches New Jersey Community Pharmacy Program in Partnership with IPC’s iCare+ Network

Clover Health Launches New Jersey Community Pharmacy Program in Partnership with IPC’s iCare+ Network

WILMINGTON, Del., July 09, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), a leading Medicare Advantage company committed to affordable, high-quality care, today announced the launch of a new...

VIIGROUP and 360Medlink Complete Merger to Deliver AI Powered Digital Medicine Solutions

VIIGROUP and 360Medlink Complete Merger to Deliver AI Powered Digital Medicine Solutions

Transforming Life Sciences with AI Driven, Clinically Validated Digital Medicine Solutions for Patients, Payors and Providers BETHLEHEM, PA, UNITED STATES, July 9, 2025 /⁨EINPresswire.com⁩/ -- VIIGROUP Inc., a leader in generative AI healthcare...

Dr. Mark Hawass selected as Top Doctor of the Year in Regenerative and Functional Medicine by IAOTP

Dr. Mark Hawass selected as Top Doctor of the Year in Regenerative and Functional Medicine by IAOTP

Dr. Mark Hawass honored member of the International Association of Top Professionals (IAOTP) will be honored at their annual awards gala in Las Vegas NEW YORK, NY, UNITED STATES, July 9, 2025 /⁨EINPresswire.com⁩/ -- Dr. Mark Hawass, a highly...

Tonix Pharmaceuticals Announces On-line Publication of Phase 3 RESILIENT Trial Results of TNX-102 SL for Fibromyalgia in the Peer Reviewed Journal, Pain Medicine

Tonix Pharmaceuticals Announces On-line Publication of Phase 3 RESILIENT Trial Results of TNX-102 SL for Fibromyalgia in the Peer Reviewed Journal, Pain Medicine

The previously disclosed and now published RESILIENT data show that once-nightly TNX-102 SL achieved statistically significant improvement in the primary endpoint of reducing fibromyalgia pain versus placebo, and was generally well tolerated These...

Department of Justice Subpoenas Doctors and Clinics Involved in Performing Transgender Medical Procedures on Children

Department of Justice Subpoenas Doctors and Clinics Involved in Performing Transgender Medical Procedures on Children

WASHINGTON — Today, the Department of Justice announced that it has sent more than 20 subpoenas to doctors and clinics involved in performing transgender medical procedures on children. The Department’s investigations include healthcare fraud,...

Evoke Pharma Receives Notice of Allowance for U.S. Patent Application for GIMOTI Extending Orange Book listings to 2036

Evoke Pharma Receives Notice of Allowance for U.S. Patent Application for GIMOTI Extending Orange Book listings to 2036

SOLANA BEACH, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal...

Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA’s Clinical Hold on Gene Therapy Trial – Hagens Berman

Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA’s Clinical Hold on Gene Therapy Trial – Hagens Berman

SAN FRANCISCO, July 09, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit styled Ho v. Rocket Pharmaceuticals, Inc., et al., No. 3:25-cv-10049 (D. N.J.) has been filed and seeks to represent investors who purchased or otherwise acquired...

Verrica Pharmaceuticals Reports Strong Growth in YCANTH® Dispensed Applicator Units in 2Q 2025

Verrica Pharmaceuticals Reports Strong Growth in YCANTH® Dispensed Applicator Units in 2Q 2025

– Company reports sequential quarterly growth of 32.8% over Q1 2025 with a record 13,434 YCANTH® dispensed applicator units in Q2 2025 – – Company reports receipt of $8 million milestone payment from its Japanese development partner, Torii...

Revolution Medicines and Iambic Announce Technology and Research Collaboration Using Iambic’s AI Discovery Tools to Pursue New Drug Candidates

Revolution Medicines and Iambic Announce Technology and Research Collaboration Using Iambic’s AI Discovery Tools to Pursue New Drug Candidates

Custom-built model will be trained using Revolution Medicines’ proprietary data to discover novel drug candidates Iambic to receive up to $25 million through a combination of upfront and expected near-term performance-based milestone payments for...

Idaho Bureau of Emergency Medical Services joins Idaho Military Division

Idaho Bureau of Emergency Medical Services joins Idaho Military Division

Posted on Jul 9, 2025 | updated: Jul 9, 2025 The Idaho Military Division is excited to welcome the state’s Bureau of Emergency Medical Services into the organization. This transition, effective July 1, 2025, marks a significant step toward...

Unlocking the mystery behind Barrett's esophagus

Unlocking the mystery behind Barrett's esophagus

A team led by researchers at Baylor College of Medicine and Washington University School of Medicine has shed light on the process that drives Barrett’s esophagus formation. This condition affects the lining of the esophagus – the tube that...

Salarius Pharmaceuticals’ Seclidemstat Demonstrates Supporting Role in Inhibiting Validated Oncology Target LSD1 in Two Recently Published Studies

Salarius Pharmaceuticals’ Seclidemstat Demonstrates Supporting Role in Inhibiting Validated Oncology Target LSD1 in Two Recently Published Studies

Phase 1/2 clinical study evaluating seclidemstat in patients with MDS and CMML is progressing with updates expected later this year Company continues to advance its contemplated merger with Decoy Therapeutics HOUSTON, July 09, 2025 (GLOBE...

Helius Medical Technologies, Inc. Compliant with Nasdaq’s Continued Listing Requirements

Helius Medical Technologies, Inc. Compliant with Nasdaq’s Continued Listing Requirements

NEWTOWN, Pa., July 09, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits,...

Idaho Bureau of Emergency Medical Services joins Idaho Military Division

Idaho Bureau of Emergency Medical Services joins Idaho Military Division

Posted on Jul 9, 2025 | updated: Jul 9, 2025 The Idaho Military Division is excited to welcome the state’s Bureau of Emergency Medical Services into the organization. This transition, effective July 1, 2025, marks a significant step toward...

Adial Pharmaceuticals Files PCT Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to at least 2045

Adial Pharmaceuticals Files PCT Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to at least 2045

GLEN ALLEN, Va., July 09, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and...

Medical Supplierz Introduces Tool to Compare Prices and Suppliers for Medical Equipment

Medical Supplierz Introduces Tool to Compare Prices and Suppliers for Medical Equipment

KUWAIT, KUWAIT, July 3, 2025 /⁨EINPresswire.com⁩/ -- Medical Supplierz has launched a dedicated feature within its B2B healthcare marketplace to support seamless buying and selling of laboratory equipment. This development addresses long-standing...

Regal Medical Group, Lakeside Community Healthcare and ADOC Medical Group Add RadNet’s AI-Powered Enhanced Breast Cancer Detection (EBCD) Program to its Membership Benefits in Southern California

Regal Medical Group, Lakeside Community Healthcare and ADOC Medical Group Add RadNet’s AI-Powered Enhanced Breast Cancer Detection (EBCD) Program to its Membership Benefits in Southern California

Program will increase access to cutting-edge AI-powered breast cancer detection and is designed to boost compliance with annual cancer-screening guidelines Regal Medical Group, Lakeside Community Healthcare and ADOC Medical Group are affiliates of...

HNL Lab Medicine Named Empowering Women Award Recipient for 2025

HNL Lab Medicine Named Empowering Women Award Recipient for 2025

ALLENTOWN, Pa., July 09, 2025 (GLOBE NEWSWIRE) -- HNL Lab Medicine has been named a recipient of the 2025 Empowering Women Award by Lehigh Valley Business and Central Penn Business Journal, in recognition of its strong commitment to advancing...

Connect Biopharma’s Exclusive Licensee in China, Simcere Pharmaceutical, Announced Submission of its New Drug Application for Rademikibart for the Treatment of Atopic Dermatitis in China

Connect Biopharma’s Exclusive Licensee in China, Simcere Pharmaceutical, Announced Submission of its New Drug Application for Rademikibart for the Treatment of Atopic Dermatitis in China

SAN DIEGO, July 09, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”, “Connect”, or the “Company”), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of...

Dandy Launches America’s First Two-Visit Dentures for Medicaid, Medicare, and Low-Paying PPOs

Dandy Launches America’s First Two-Visit Dentures for Medicaid, Medicare, and Low-Paying PPOs

NEW YORK, July 09, 2025 (GLOBE NEWSWIRE) -- Dandy, America’s fully digital dental lab, today announced the first premium denture solution priced for government health plans*. With its two-appointment workflow and turnaround in less than 10 days,...

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service